Thoughts
Jun 26, 2025
Proteomics at the speed of Drug Discovery: Accelerating Programs to Clinic
Explore the potential of an end-to-end proteomics platform in transforming drug discovery at Johnson & Johnson (J&J). Learn how J&J utilizes Mass Dynamics 3.0 for effective data handling, analytics, and visualization. Discover the benefits of standardizing and automating proteomics to enhance portfolio impact.
Thoughts
Proteomics at the speed of Drug Discovery: Accelerating Programs to Clinic
Explore the potential of an end-to-end proteomics platform in transforming drug discovery at Johnson & Johnson (J&J). Learn how J&J utilize...
June 26, 2025
Customer Stories
Accelerating Discovery through Collaborative Multiomics at PTC Therapeutics
"Mass Dynamics is fast, user-friendly, and above all, collaborativ. I really wish for Mass Dynamics to become the leader in the data analys...
May 21, 2025
Customer Stories
Bridging Worlds: Translating Complex Technology into Biological Insights
Discover how Jason Rogalski and his team is transforming the way researchers approach complex proteomics data at the University of British ...
March 28, 2025